Back
ESC Professional Premium Access

COVID-19 vaccine-induced myocarditis vs. Immune checkpoint inhibitor-induced myocarditis - Same but different?

Session: COVID-19 and cardiovascular disease in special populations
Topic: Cardio-Oncology
Speaker: Doctor M. Laufer-Perl (Tel Aviv, IL)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Michal Laufer-Perl

Tel Aviv Sourasky Medical Center, Tel Aviv (Israel)
0 follower

5 more presentations in this session

Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Access
Abstract
Slides
Like
Thumbnail

Predictors and clinical consequences of heart damage in CMR in patients after COVID-19

Speaker: Doctor M. Chudzik (Warsaw, PL)

Access
Abstract
Slides
Like
Thumbnail

Parameters of coagulation and platelet hyperreactivity reflect an increased mortality in patients with moderate to severe COVID-19

Speaker: Mr K. Jakobs (Berlin, DE)

Access
Abstract
Slides
Like
Thumbnail

Galectin-3 as a possible marker for increased thrombogenicity in COVID-19

Speaker: Ms M. Puccini (Berlin, DE)

Access
Abstract
Slides
Like
Thumbnail

Pragmatic observations from a post-Covid-19 cardiac evaluation register: prevalence of cardiological alterations from a basic diagnostic sequence and contribution of the clinical hystory.

Speaker: Doctor G. Ruiz (Buenos Aires, AR)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

COVID-19 and cardiovascular disease in special populations

Speakers: Doctor M. Laufer-Perl, Doctor I. Ikonomidis, Doctor M. Chudzik, Mr K. Jakobs, Ms M. Puccini...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources